lori lombardi md, mark a. terry md, neda shamie md, anand k. shah md, daniel j. friend ms *dr. terry...
TRANSCRIPT
![Page 1: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/1.jpg)
SURGEON-CUT VERSUS PRE-CUT DONOR TISSUE IN
DESCEMET’S STRIPPING AND AUTOMATED
ENDOTHELIAL KERATOPLASTY (DSAEK)
Lori Lombardi MD, Mark A. Terry MD,Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend
MS*Dr. Terry has a financial interest in Bausch & Lomb instruments he
developed for DSAEKOther authors have no financial interest
DD
![Page 2: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/2.jpg)
Introduction DSAEK surgery has revolutionized treatment for
various forms of corneal endothelial dysfunction Successful replacement of damaged
endothelium with graft tissue relies on surgical technique as well as favorable tissue characteristics
Previously, surgeons prepared the donor posterior lenticule at the time of surgery
Now, “precut” donor tissue may be prepared by the tissue bank using a Moria microkeratome and artificial anterior chamber system
![Page 3: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/3.jpg)
Purpose
This large scale, prospective study compares outcomes of DSAEK surgery using surgeon-cut versus pre-cut donor tissue
![Page 4: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/4.jpg)
Methods
Patients were enrolled in an Institutional Review Board approved protocol for endothelial keratoplasty
Surgical data was gathered in a prospective fashion
Consecutive DSAEK surgeries were compared using Surgeon-cut tissue (n=114) versus Pre-cut tissue (n=207).
Outcome measures reviewed include: Best spectacle corrected visual acuity (BSCVA) Endothelial cell loss Rate of primary graft failure Graft dislocation rate
![Page 5: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/5.jpg)
Results
Average BSCVA at 6 months: 20/37 for the Surgeon-cut group (n=114) 20/38 for the Pre-cut group (n=207) p = 0.745
Average BSCVA at 1 year: 20/33 for the Surgeon-cut (n=108) 20/42 for the Pre-cut (n=112) p = 0.044
With comorbidities removed, BSCVA at 1 year: 20/33 for the Surgeon-cut (n=106) 20/41 for Pre-cut (n=108) p = 0.72
![Page 6: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/6.jpg)
Best Spectacle-Corrected Visual Acuity
Six Months One Year0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
BSCVA (Co-morbidities removed)
PrecutSurgeon cut
Time
LogM
AR
VA
20/38
p = 0.745
20/41
20/33
p = 0.72
20/37
![Page 7: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/7.jpg)
Endothelial Cell Loss
Endothelial cell loss at 6 months: Surgeon-cut = 35% Pre-cut = 29% p=0.002
Endothelial cell loss at 1 year: Surgeon-cut = 36% Pre-cut = 29% p = 0.009
![Page 8: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/8.jpg)
Endothelial Cell Loss
Six Months One Year0%
5%
10%
15%
20%
25%
30%
35%
40%
Endothelial Cell Loss
Precut
Surgeon cut
Time
Perc
en
t C
ell L
oss
p = 0.009p = 0.002
29% 29%
35%36%
![Page 9: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/9.jpg)
Complications
Primary graft failures: No primary graft failures occurred in either
group Dislocations:
Two dislocations occurred in the Surgeon-cut group
Ten dislocations in the Pre-cut group p=0.421
![Page 10: Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments](https://reader035.vdocuments.us/reader035/viewer/2022072016/56649ee85503460f94bf97d5/html5/thumbnails/10.jpg)
Conclusion
In this large-scale, prospective study, DSAEK using either Surgeon-cut or Pre-cut tissue resulted in comparable patient outcomes and surgical results
BSCVA was not statistically different between groups
Endothelial loss was higher in Surgeon-cut tissue Dislocations occurred more often in the Pre-cut
group Study includes graft preparation and surgery
performed by less experienced surgeons, which may factor into the overall outcomes